6
total announcements
539730.BO · 15 min delayed
Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has published un-audited financial results for the quarter ended 30th June, 2026, as approved by the Board in its meeting held on 05th August, 2026.
Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has published un-audited financial results for the quarter ended 30th June, 2026, as approved by the Board in its meeting held on 5th August, 2026. The results were published in newspapers on 6th August, 2026.
Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has announced its unaudited financial results for Q1 FY27, with revenue jumping 90%, EBITDA surging 93%, and profit rising 95% YoY. The company has also allotted 1.10 crore Bonus Equity Shares in a 2:1 ratio to eligible shareholders.
Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has announced the outcome of its Board Meeting, which included the adoption and approval of the un-audited financial results for the quarter ended June 30, 2026, along with a limited review report by its statutory auditor.
Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditor, M/s. R.H. Nisar & Co. The trading window for insiders closed on July 1, 2026, and the board meeting commenced at 10:30 a.m. and concluded at 11:20 a.m.
Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/08/2026 to consider and approve the Unaudited Financial Results for the first quarter ended 30/06/2026.